Not so fast: Phase III Biosimilar Clinical Trial & Infringement Threat does not Create Justiciable Case or Controversy December 8, 2014PatentClaim Construction, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post. Login